Acute pancreatitis linked to bevacizumab: A case report
Introduction: The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly being used in the treatment of malignant tumors. It is the first molecular-targeted agent used in the treatment of several ovarian cancers. The typical side effects of this drug are hypertension...
Main Authors: | Arif Hakan Önder, Banu Öztürk, Ali Murat Tatlı, Erkan Kayıkçıoğlu |
---|---|
Format: | Article |
Language: | English |
Published: |
Turkiye Klinikleri
2018-08-01
|
Series: | Journal of Oncological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S245233641730105X |
Similar Items
-
An extremely rare neoplasm, histiocytic sarcoma: A report of two cases with an aggressive clinical course
by: Erkan Kayikcioglu, et al.
Published: (2017-07-01) -
Hypertrygliceridemia-induced Acute Pancreatitis Following Hyperlipidemic Abdominal Crisis
by: Serhat Akay, et al.
Published: (2011-08-01) -
Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Ali AL Zahrani, et al.
Published: (2021-03-01) -
A rare entity in ED: Normal lipase level in acute pancreatitis
by: Onder Limon, et al.
Published: (2016-03-01) -
PANCREATIC PSEUDOCYST AS A COMPLICATION OF ACUTE ALCOHOLIC PANCREATITIS – CASE REPORT
by: Snežana Tešić-Rajković, et al.
Published: (2010-06-01)